Data of the article "The physiological cost of being hot: High thermal stress and disturbance decrease energy reserves in dragonflies in the wild" by Eduardo Ulises Castillo-Pérez (20869904)

“…Despite this, individuals from disturbed sites were larger but had lower energy reserves than those from preserved sites. …”

Comparison of the studied complete blood count parameters between <i>Anaplasma</i> spp. and <i>A. ovis</i> positive and negative goats enrolled from Dera Ghazi Khan district in Pun... by Sumaira Sumaira (21453523)

Linear regressions of consumer stable carbon and nitrogen isotope values and collection date. by Nathan D. McTigue (10706460)

Mathematical treatments applied to data to correct stable isotope values for lipid content. by Nathan D. McTigue (10706460)

The higher the value, the stronger the correlation. by Xiaoxu Zhu (11764430)

The Ka/Ks values of PtWRKY paralogous gene pairs. by Yuzhao Ma (12840632)

“…All poplar WRKY proteins are hydrophilic, located in the cell nucleus, and form target relationships with a large number of miRNAs, with their promoter containing a large number of stress defense elements. …”

Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Prediction (a-d) and infusion deviation (e-f) results under different training sets and test sets. by Leijie Wang (21485157)

Bidirectional grey-matter CBF changes induced by a hypercapnic challenge. by Juliana Zimmermann (10507091)

Modelled policy outcomes, with posterior values for individual nodes ranked from 1-5 across the parties - Green, Reform UK, Liberal Democrat, Conservative, and Labour, where 1 is the lowest rank and 5 is the highest. The parties are ranked for each policy node in the network (e.g., income tax), based on the direction of change (“performance indicator”) stated in the first column (e.g., lowest, highest, most, improvement). For example, a value of 5 for Green tax means that green tax is lowest under Reform UK’s policies, while a value of 1 means that green tax is highest under the Green Party’s policies. Larger text in bold and italic font indicates that the directional change (i.e., increase or decrease) of a node under a party’s policies is consistent with the direction indicated, whereas black text indicates an opposite directional change (e.g., income tax is predicted to decrease under Reform UK in alignment with the performance indicator, and increase under Green and Labour). by Richard Stafford (174326)

“…Larger text in bold and italic font indicates that the directional change (i.e., increase or decrease) of a node under a party’s policies is consistent with the direction indicated, whereas black text indicates an opposite directional change (e.g., income tax is predicted to decrease under Reform UK in alignment with the performance indicator, and increase under Green and Labour).…”

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)